CN100379441C - 降糖通络中药制剂 - Google Patents
降糖通络中药制剂 Download PDFInfo
- Publication number
- CN100379441C CN100379441C CNB2005100325786A CN200510032578A CN100379441C CN 100379441 C CN100379441 C CN 100379441C CN B2005100325786 A CNB2005100325786 A CN B2005100325786A CN 200510032578 A CN200510032578 A CN 200510032578A CN 100379441 C CN100379441 C CN 100379441C
- Authority
- CN
- China
- Prior art keywords
- blood sugar
- chinese medicine
- medicinal preparation
- chinese medicinal
- sugar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 239000003814 drug Substances 0.000 claims abstract description 28
- 239000002994 raw material Substances 0.000 claims abstract description 4
- GMBQZIIUCVWOCD-WWASVFFGSA-N Sarsapogenine Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)C[C@H]4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@H](C)CO1 GMBQZIIUCVWOCD-WWASVFFGSA-N 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000002775 capsule Substances 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 8
- 239000008187 granular material Substances 0.000 claims description 7
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 claims description 6
- RTMWIZOXNKJHRE-UHFFFAOYSA-N Tigogenin Natural products CC1COC2CC(C)(OC12)C3CCC4C5CCC6CC(O)CCC6(C)C5CCC34C RTMWIZOXNKJHRE-UHFFFAOYSA-N 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 5
- 238000002481 ethanol extraction Methods 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 239000004615 ingredient Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 229930183118 Tanshinone Natural products 0.000 claims description 3
- 238000000465 moulding Methods 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- -1 decoction Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 31
- 210000004369 blood Anatomy 0.000 abstract description 31
- 230000000694 effects Effects 0.000 abstract description 14
- 208000011580 syndromic disease Diseases 0.000 abstract description 9
- 201000010099 disease Diseases 0.000 abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 4
- 239000000796 flavoring agent Substances 0.000 abstract description 4
- 235000019634 flavors Nutrition 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 230000003247 decreasing effect Effects 0.000 abstract 9
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 abstract 1
- 241000605445 Anemarrhena asphodeloides Species 0.000 abstract 1
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract 1
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 abstract 1
- 206010051151 Hyperviscosity syndrome Diseases 0.000 abstract 1
- 244000132619 red sage Species 0.000 abstract 1
- 239000000047 product Substances 0.000 description 12
- 241000700159 Rattus Species 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 7
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 241000605447 Anemarrhena Species 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 208000007241 Experimental Diabetes Mellitus Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010020850 Hyperthyroidism Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 210000004100 adrenal gland Anatomy 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000282817 Bovidae Species 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010041956 Stasis syndrome Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 208000005634 blind loop syndrome Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000012846 chemical reference substance Substances 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 238000012850 discrimination method Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100325786A CN100379441C (zh) | 2005-12-20 | 2005-12-20 | 降糖通络中药制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100325786A CN100379441C (zh) | 2005-12-20 | 2005-12-20 | 降糖通络中药制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1824137A CN1824137A (zh) | 2006-08-30 |
CN100379441C true CN100379441C (zh) | 2008-04-09 |
Family
ID=36935079
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100325786A Expired - Fee Related CN100379441C (zh) | 2005-12-20 | 2005-12-20 | 降糖通络中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100379441C (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103055154A (zh) * | 2012-12-07 | 2013-04-24 | 贺志弘 | 一种基于重建内稳态理论的通络降糖黑茶及制备方法 |
CN109091631A (zh) * | 2018-09-06 | 2018-12-28 | 郑州大学第附属医院 | 治疗早期糖尿病肾病的当归黄芪治疗试剂及制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1238986A (zh) * | 1999-06-24 | 1999-12-22 | 齐福东 | 一种糖尿病保健口服液 |
CN1370585A (zh) * | 2002-03-06 | 2002-09-25 | 黄资源 | 一种治疗2型糖尿病的复方中药制剂 |
CN1418689A (zh) * | 2002-11-29 | 2003-05-21 | 张慧芳 | 一种治疗糖尿病的药物组合物及其制备方法 |
-
2005
- 2005-12-20 CN CNB2005100325786A patent/CN100379441C/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1238986A (zh) * | 1999-06-24 | 1999-12-22 | 齐福东 | 一种糖尿病保健口服液 |
CN1370585A (zh) * | 2002-03-06 | 2002-09-25 | 黄资源 | 一种治疗2型糖尿病的复方中药制剂 |
CN1418689A (zh) * | 2002-11-29 | 2003-05-21 | 张慧芳 | 一种治疗糖尿病的药物组合物及其制备方法 |
Non-Patent Citations (2)
Title |
---|
中医药治疗2型糖尿病近况. 路志敏等.河北中医,第24卷第3期. 2002 * |
中医药治疗糖尿病研究概况. 蔡仲德等.中国实验方剂学杂志,第8卷第6期. 2002 * |
Also Published As
Publication number | Publication date |
---|---|
CN1824137A (zh) | 2006-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103566350B (zh) | 一种具有降血糖作用的药物组合物 | |
CN104757540A (zh) | 辅助降糖的保健品及其制备方法 | |
CN108578544A (zh) | 一种具有降糖作用的中药组合物及其制备方法与应用 | |
CN105267755A (zh) | 降糖口服液 | |
CN103223111A (zh) | 一种治疗糖尿病肾病的中药组合物及其制备方法 | |
CN101238894B (zh) | 具有改善睡眠功能的保健食品及其制备方法 | |
CN114377161A (zh) | 一种经典名方开心散的灭菌方法 | |
CN105935374A (zh) | 全麻素在制备治疗消渴症药物中的应用 | |
CN1558768A (zh) | 一种中药组合物及其制备方法 | |
CN100379441C (zh) | 降糖通络中药制剂 | |
CN102697781A (zh) | 胡芦巴碱作为制备防治糖尿病及其并发症药物的应用 | |
CN104474472A (zh) | 具有降三高作用的苦丁茶含片及其生产方法 | |
CN106822583A (zh) | 一种调节血压、血脂、血糖的中药组合物及其制备方法 | |
CN1315499C (zh) | 治疗糖尿病及并发症的药物及其制备方法 | |
CN100409880C (zh) | 一种治疗高脂血症的蒙药保利尔及其制备方法 | |
CN103520684B (zh) | 一种降血糖的中药复合物 | |
CN102293855A (zh) | 治疗脾肾两虚型糖尿病肾病的中药组合物及其制备方法与应用 | |
CN110025011A (zh) | 一种增强免疫力的麦冬人参含片 | |
CN101406576B (zh) | 一种治疗糖尿病的中药及制备方法 | |
CN101293059B (zh) | 一种治疗糖尿病的中药复方制剂 | |
CN105535070B (zh) | 治疗糖尿病的药物组合物及其制备方法和应用 | |
CN101700310A (zh) | 复方虫草降糖中药制剂 | |
CN104352748A (zh) | 一种治疗糖尿病肾病的中药组合物及其制备方法 | |
CN108478701A (zh) | 一种增强免疫力的含片 | |
CN101444609B (zh) | 一种具有戒毒作用的中药及其制备工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: HUNAN JIUDIAN PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: HUNAN INST OF TRADITIONAL CHINESE MEDICINE Effective date: 20070713 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20070713 Address after: 410011, seven building, Xin Tian mansion, No. 78 North Shaoshan Road, Hunan, Changsha Applicant after: Hunan Jiudian Pharmaceutical Co., Ltd. Address before: 410013 Institute of traditional Chinese medicine, Changsha Academy of traditional Chinese medicine, Tongzi Road, Hunan Province, China Applicant before: Hunan Traditional Chinese Medicine Institute |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JIANGSU YUNYANG GROUP MEDICAL CO., LTD. Free format text: FORMER OWNER: HUNAN JIUDIAN PHARMACEUTICAL CO., LTD. Effective date: 20101015 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 410011 7/F, XINTIAN BUILDING, NO.78, SHAOSHAN NORTH ROAD, CHANGSHA CITY, HUNAN PROVINCE TO: 212300 NO.8, BAWEI ROAD, ECONOMIC DEVELOPMENT ZONE, DANYANG CITY, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20101015 Address after: 212300 No. eight, No. 8, weft Road, Danyang Economic Development Zone, Jiangsu, China Patentee after: Jiangsu Yunyang Pharmaceutical Group Co., Ltd. Address before: 410011, seven building, Xin Tian mansion, No. 78 North Shaoshan Road, Hunan, Changsha Patentee before: Hunan Jiudian Pharmaceutical Co., Ltd. |
|
DD01 | Delivery of document by public notice |
Addressee: Fan Ming Document name: Notice of termination of patent |
|
DD01 | Delivery of document by public notice | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080409 Termination date: 20191220 |
|
CF01 | Termination of patent right due to non-payment of annual fee |